What does a CT scan showing volume loss, periventricular ischemic white matter disease with microangiopathic changes mean in an 80-year-old male?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CT Findings of Volume Loss, Periventricular Ischemic White Matter Disease with Microangiopathic Changes

The CT scan findings indicate cerebral small vessel disease (CSVD), which is causing damage to the small blood vessels in your brain, leading to chronic ischemic changes in the white matter and brain atrophy. 1

What These Findings Mean

Small Vessel Disease

  • Your CT scan shows evidence of cerebral small vessel disease, which affects the small arteries, arterioles, capillaries, and small veins that supply the white matter and deep structures of the brain 2
  • This is characterized by:
    • Volume loss (brain atrophy): Shrinkage of brain tissue
    • Periventricular ischemic white matter disease: Areas of damage in the white matter surrounding the ventricles due to reduced blood flow
    • Microangiopathic changes: Damage to small blood vessels

Clinical Significance

Pathophysiology

  • These changes result from:
    • Small vessel arteriolosclerosis (hardening of small arteries) 1
    • Chronic reduction in blood flow to white matter regions 3
    • Possible blood-brain barrier dysfunction 1
    • Microvessel stenosis (narrowing) 4

Risk Factors

  • Age (very common in people over 80) 2
  • Hypertension
  • Diabetes
  • Smoking
  • Other vascular risk factors

Clinical Implications

Cognitive Impact

  • These findings are associated with:
    • Increased risk of cognitive decline
    • Possible vascular cognitive impairment 1
    • Executive function difficulties (planning, organizing)
    • Processing speed reduction
    • Memory problems

Stroke Risk

  • Increased risk of:
    • Lacunar strokes (small strokes in deep brain structures) 5
    • Contributes to approximately 20% of all strokes 2

Other Symptoms

  • May contribute to:
    • Gait disturbances (walking problems)
    • Balance issues
    • Depression
    • Urinary symptoms

Management Considerations

Vascular Risk Factor Control

  • Aggressive management of:
    • Blood pressure (most important)
    • Diabetes
    • Cholesterol
    • Smoking cessation

Medication Considerations

  • Antiplatelet therapy may be considered
  • Careful medication review to avoid drugs that could worsen cognitive function

Monitoring

  • Regular cognitive assessments
  • Follow-up brain imaging may be needed to monitor progression
  • Screening for other vascular diseases

Prognosis

  • CSVD is typically chronic and progressive 2
  • The severity of white matter changes correlates with worse clinical outcomes 6
  • Early intervention to control vascular risk factors may slow progression

Important Distinctions

  • These findings differ from large vessel strokes or other neurological conditions
  • The pattern of periventricular white matter disease is characteristic of small vessel ischemic disease rather than other conditions like multiple sclerosis or inflammatory disorders 1

These findings are common in individuals your age but warrant attention to prevent further progression and reduce the risk of stroke and cognitive decline.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cerebral small vessel disease: A review.

Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2021

Research

CT perfusion quantification of small-vessel ischemic severity.

AJNR. American journal of neuroradiology, 2008

Research

Leukoaraiosis and lacunes are associated with poor clinical outcomes in ischemic stroke patients treated with intravenous thrombolysis.

International journal of stroke : official journal of the International Stroke Society, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.